Hem › Endometriecancer › District of Columbia › Washington
Kliniska studier för Endometriecancer i Washington, DC
18 studier för Endometriecancer söker deltagare vid platser i och runt Washington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekryterarFas 3
- MedStar Washington Hospital Center, Washington D.C.
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekryterarFas 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi bort
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
RekryterarFas 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekryterarFas 1
- Georgetown University Medical Center, Washington D.C.
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
RekryterarFas 3
- MedStar Washington Hospital Center, Washington D.C.
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RekryterarFas 3
- MedStar Washington Hospital Center ( Site 5005), Washington D.C.
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RekryterarFas 3
- MedStar Washington Hospital, Washington D.C.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RekryterarFas 3
- Research Site, Silver Spring · 7 mi bort
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RekryterarFas 1
- Georgetown University Medical Center, Washington D.C.
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RekryterarFas 1/2
- Children's National Medical Center, Washington D.C.
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekryterarFas 1
- Normunity Investigational Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RekryterarFas 1/2
- National Institutes of Health, Bethesda · 7 mi bort
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekryterarFas 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · 7 mi bort
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
RekryterarFas 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi bort
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi bort
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi bort
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
RekryterarFas 1
- Holy Cross Hospital, Silver Spring · 7 mi bort
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
RekryterarFas 2/3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 mi bort
Endometriecancer-studier i andra städer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Columbus, OH25 studier
- Chicago, IL25 studier
- Oklahoma City, OK25 studier
Andra studier i Washington
- Cancer (alla typer)58 studier
- Icke-småcellig lungcancer55 studier
- Bröstcancer46 studier
- Metastaserande cancer43 studier
- Lungcancer41 studier
- Prostatacancer38 studier
- Övervikt33 studier
- Kolorektal cancer29 studier
- Hjärt-kärlsjukdom28 studier
- Blåscancer26 studier
- Akut myeloid leukemi24 studier
- Äggstockscancer23 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.